Sign in

CIK 0000875045

  • Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330112644
Phone
+1 617-679-2000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
  1. 4 Grant or award Director acquired 775 shares (grant or award)
  2. 4 Grant or award Director acquired 775 shares (grant or award)
  3. 4 Grant or award Director acquired 775 shares (grant or award)
  4. 4 Exercise or conversion Chief Accounting Officer acquired 251 shares (option exercise)
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market sale Head of Research & Development sold 7,672 shares at $440.00 ($3,375,680)
  8. 4 Open-market sale Head of Glob Prod Strat & Com sold 3,087 shares at $440.00 ($1,358,280)
  9. 4 Open-market sale Director sold 360 shares at $274.17 ($98,701)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Shares withheld for taxes Chief Executive Officer gave up 14,473 shares (to pay taxes)
  19. 4 Shares withheld for taxes EVP, Research & Development gave up 3,510 shares (to pay taxes)
  20. 4 Shares withheld for taxes SVP, Chief Accounting Officer gave up 115 shares (to pay taxes)

Page 14 of 86 · 1,714 filings